Post-earnings recap
Reported
Tue, Jul 28, 2026
EPS actual
$6.06
EPS est.
$5.12
EPS surprise
+18.36%
1-day move
+1.63%
Chemed Corporation reported a strong earnings per share figure, exceeding expectations by over 18%. This positive surprise likely contributed to the stock's 1.63% increase following the earnings announcement. However, without revenue figures or management commentary, it's difficult to assess the overall performance and future outlook.
| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $6.06 | N/A | +18.36% |
| Revenue | N/A | N/A | N/A |
No transcript is on record, and the analysis is based solely on numerical results.
Chemed Corporation operates in the health care sector, primarily providing hospice and palliative care services. With a market cap of $7 billion, the company plays a crucial role in the growing demand for health care services as the population ages.
Last quarter
In Q1-2026, Chemed reported an EPS of $5.65, beating estimates by 16.49%. The stock reacted positively, gaining 2.63% the following day.
EPS beat streak
2Q
EPS beat rate
75%
Avg EPS surprise
+4.42%
Avg 1-day reaction
+0.55%
Investors are cautiously optimistic ahead of the earnings report, given the company's strong performance in the last quarter. However, there are concerns about potential revenue misses.
Bull case
If Chemed continues its trend of beating EPS estimates, it could signal strong operational efficiency and demand for its services, leading to a positive stock reaction.
Bear case
Conversely, if the company fails to meet expectations or shows signs of slowing growth, it could lead to a negative market reaction, especially given the high implied volatility.
The print will turn on these.
Q1
What will the EPS be for Q2-2026?
The EPS figure will be crucial in determining if Chemed can maintain its trend of beating estimates, which has historically led to positive stock movements.
Q2
How is revenue growth trending in the current quarter?
Understanding revenue growth will provide insights into the company's market position and demand for its services, which are critical for future performance.
—
Est. EPS
—
Est. Rev
—
Impl. Move
±3.5%
Why consensus could be wrong
The market may underestimate Chemed's ability to sustain its growth trajectory, given its recent strong EPS performance.
Supporting evidence
The company has a 75% EPS beat rate over the last eight quarters, indicating strong management performance.
Options pricing suggests a significant move, which may reflect uncertainty rather than a clear bearish sentiment.
The recent positive stock reaction following earnings surprises indicates that investors may be overly cautious.
Key risk
If Chemed's EPS exceeds $5.80, it could invalidate bearish expectations and trigger a strong positive reaction.
Pre-commit to what would confirm each case.
This quarter's performance hinges on maintaining strong earnings and revenue growth amidst a competitive health care landscape.
Bull confirmed if
An EPS of $5.80 or higher would confirm strong operational performance and growth.
Bear confirmed if
An EPS below $5.40 would raise concerns about Chemed's profitability and market demand.
What the market is pricing for the move.
Implied Move
±13.24%
Historical Avg
±0.9%
The options market is pricing in a significant move, indicating that traders expect volatility around the earnings announcement.
Options are pricing ±13.2% while CHE has averaged ±0.9% over the last 8 prints — setup is pricing rich.
ATM IV
0.3%
30d HV
33.0%
Open-market trades by officers, directors, and 10%+ holders over the trailing 90 days.
Bought
$0.00
0 sh
0 insiders
Sold
$1.0M
2,000 sh
1 insider
Net
$1.0M
Net selling
Most Active Insiders· 1 open-market trade
$1.0M
Net selling
Smart-money positioning from the most recent 13F filings.
Institutional
106.50%
of float
Insider
1.94%
of float
Holders
699
institutions
Top Holders· as of Jun 2026
Blackrock Inc.
1,484,282 sh · $744.3M
11.36%
11.0%
Likely market behavior by outcome. Not investment advice.
Beat & raise
If Chemed beats expectations, history suggests the stock could rise by around 0.76%, confirming the company's operational strength.
In line / cautious
If results are in line with expectations, the stock may see muted movement as investors await further guidance.
Miss
A miss could lead to a decline of approximately 0.33%, reflecting investor disappointment and concerns about future growth.
The lines on the call that would change the story.
Recent Transactions
Sep 28, 2026 · @ $513.45
2,000 sh
$1.0M
Open-market trades only (Form 4 codes P/S). Awards, exercises, and tax-withholding excluded as routine compensation noise.
AQR Capital Management, LLC
972,474 sh · $487.6M
7.44%
134.0%
Vanguard Portfolio Management LLC
787,068 sh · $394.7M
6.02%
-3.5%
Vanguard Capital Management LLC
604,420 sh · $303.1M
4.62%
-5.0%
Acadian Asset Management. LLC
453,238 sh · $227.3M
3.47%
47.7%
13F filings updated quarterly. Position deltas show change in shares vs. the prior quarter.